Department of PET/CT, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, 440 Jiyan Road, 250117, Jinan, Shandong, China.
Department of Radiology, The Second Hospital of Shandong University, 247 Beiyuan Rd, 250033, Jinan, Shandong, China.
Sci Rep. 2019 Aug 29;9(1):12582. doi: 10.1038/s41598-019-49057-5.
Pulmonary tuberculosis (PTB) is a common worldwide infection with high mortality and morbidity, especially in developing countries. This study analyzed PET/CT findings in tumor patients with radiographic lesions suggesting old healed pulmonary tuberculosis (OHPTB) and imaging follow-up to find and verify PET/CT signs that may predict tuberculosis recurrence. A retrospective analysis of the tumor patients was carried out. These patients underwent 18F-FDG PET/CT in our center from 2010 to 2018. Confirmation of tuberculosis recurrence was obtained by follow-up of morphological changes in old lesions by PET/CT or CT. In total, 238 patients with a complete medical history were included in the final study, and 22 patients experienced OHPTB recurrence. We found that the SUVmax of tuberculosis in PET/CT was significantly increased in the recurrence group compared to the non-recurrence group [5.00 (3.40, 7.30) vs. 1.10 (0.80, 1.30), P < 0.001]. The ROC curve showed good discrimination, with an AUC of 0.980, and a cut-off SUVmax value of 2.15 was identified (the sensitivity was 90.5%, the specificity was 97.2%, the positive predictive value was 76.0%, and the negative predictive value was 99.1%). Both the tumor and the anti-tumor treatment can cause the patient to be immunocompromised and might further cause the recurrence of OHPTB. Positive imaging on 18F-FDG PET can predict the recurrence of OHPPT. Although there might be a false positive, 18F-FDG PET can greatly narrow the monitoring range. A negative result on imaging has high reliability for eliminating the possibility of tuberculosis recurrence. PET/CT has important clinical significance in tuberculosis management in patients with concurrent OHPTB.
肺结核(PTB)是一种常见的全球性感染病,死亡率和发病率都很高,尤其是在发展中国家。本研究分析了疑似陈旧性愈合肺结核(OHPTB)的影像学病变的肿瘤患者的 PET/CT 结果,并进行影像学随访,以寻找和验证可能预测结核病复发的 PET/CT 征象。对肿瘤患者进行了回顾性分析。这些患者于 2010 年至 2018 年在我们中心接受了 18F-FDG PET/CT 检查。通过 PET/CT 或 CT 随访陈旧病变的形态学变化来获得结核病复发的确认。共有 238 例完整病史的患者纳入最终研究,其中 22 例发生 OHPTB 复发。我们发现,PET/CT 中结核病的 SUVmax 在复发组明显高于非复发组[5.00(3.40,7.30)比 1.10(0.80,1.30),P < 0.001]。ROC 曲线显示了良好的区分度,AUC 为 0.980,确定了 SUVmax 值为 2.15 的截断值(灵敏度为 90.5%,特异性为 97.2%,阳性预测值为 76.0%,阴性预测值为 99.1%)。肿瘤和抗肿瘤治疗都会导致患者免疫功能低下,可能进一步导致 OHPTB 的复发。18F-FDG PET 的阳性影像学表现可以预测 OHPPT 的复发。虽然可能存在假阳性,但 18F-FDG PET 可以大大缩小监测范围。影像学阴性结果对排除结核病复发的可能性具有高度可靠性。在合并 OHPTB 的患者中,PET/CT 在结核病管理中具有重要的临床意义。